stocks · Thursday, May 7, 2026 · 3 min
A 10%+ owner bought $9.2M of Sportradar at $13.21: buy SRAD at $14.12, stop $11.66
A large shareholder of Sportradar dropped $9.2 million buying the stock near 52-week lows, the biggest insider purchase in our scan this week. Sports-betting infrastructure just got a regulatory tailwind from a CFTC letter on prediction markets. Buy SRAD at $14.12, stop $11.66.
Your guide reads 50+ feeds so you do not have to. Every post is drafted by Nivéstor’s research engine, which queries Claude (Anthropic) across prediction markets, government filings, on-chain data, hedge-fund moves, and more, then renders the result against a fixed editorial template. No human edits the draft before publication. Methodology · Track record.
Aim for $16.73: 50-day moving average; first level where the downtrend would mechanically stall
Aim for $19.00: April breakdown gap that has not yet filled
Why this size: Risk 0.5% of account at the stop. Stop is 17.4% below entry ($14.12 to $11.66), so raw position = 0.5% / 17.4% = 2.9% of account. Round to 3%. The wide stop is the cost of buying near a 52-week low; size has to come down to compensate.
When you'd hold this: 6 to 12 weeks, around Q1 earnings expected mid-May, roughly 7 to 14 days from today
Someone who already owns more than 10% of Sportradar, the company that sells data and odds to every legal sportsbook in the US, just bought another 697,893 shares for $9.2 million on May 41. That is the single biggest insider purchase in any US stock we tracked this week, and they did it with the stock sitting near its lowest price in a year. The market noticed today: the stock is up 8% on the open. Buy SRAD around $14.12 and bail if it closes below $11.66.
What just happened
Sportradar makes the data that powers sports betting. When you place a live bet on a basketball game and the odds update every few seconds, that is a Sportradar feed in the background. The stock has been cut roughly in half from its 52-week high of $32.22.
On May 4 a holder who already owned 3.1 million shares bought another 697,893 at $13.21 each, a $9.2 million purchase that bumped their stake by 23%1. That filing hit the public record on May 6, and today, May 7, the stock is up 8% to $14.12 on volume that is meaningfully above its recent average.
This is the kind of trade insiders do when they think the bottom is in. Buying a 23% larger stake near 52-week lows with cash, not options, is the highest-conviction signal in the insider data set.
So what
Here is the chain. Sportradar's price has been weighed down by two worries: legal sports betting growth slowing in the US, and competition from prediction markets like Kalshi and Polymarket that let you bet on game outcomes without going through a regulated sportsbook.
On May 1 the Commodity Futures Trading Commission, the federal regulator that oversees those prediction markets, issued a supplemental letter softening some of the reporting requirements on those venues2. That is generally read as a green light: prediction markets get to keep operating, and the sports-betting universe gets bigger overall, not smaller.
A bigger sports-betting universe means more demand for the live data feeds that price every game, every quarter, every shot. Sportradar sells that data to both the regulated sportsbooks and, increasingly, to the prediction-market venues themselves. So the regulatory news that the market read as bad for legacy sportsbooks is actually neutral to good for the company that sells the picks-and-shovels to all of them.
That is why a 10%+ owner is buying the dip with $9.2 million of cash: the read across two domains, insider filings plus regulatory developments, points to a wider customer base over the next year, not a narrower one.
What to do about it
Buy SRAD around $14.12. If it closes below $11.66, the trade is wrong, get out. The first profit-taking level is $16.73, the average price of the last 50 trading days, which is roughly 18% above where it is now. The bigger target is $19.00, which is where the stock gapped down in April and has not yet filled.
Main risk: this is a small-cap with daily volume around 130,000 shares, which means it can swing 5% on a single news headline. Size accordingly, this is not a 10% position.
What we got right (and wrong) before
We have not published on sports-betting names recently, so there is no closed call to compare to. Our last several posts have been concentrated in energy and shipping, which is exactly why we are forcing a different domain here, an insider-driven setup in a beaten-down small cap.
For the nerds
The insider on the May 4 trade is a Form 4 "title 7" filer (10%+ beneficial owner), 697,893 shares purchased at $13.21, value $9,220,679, deltaOwn +23%, filed 2026-05-061. SRAD daily quote: $14.12, +8.2% intraday, prev close $13.053. RSI(14) 32.67, weakening and approaching oversold band per the standard 30-to-40 bucket. MACD histogram +0.052 (just turned positive after a long red run). 50-day SMA $16.73, 200-day SMA $22.64; price below both, so the long-term trend is still down. 52-week range $11.66 to $32.22, current price 16% above the low. Volume today 133k vs. typical 200k, light but it is the open. CFTC reference: release 9226-26, dated 2026-05-01, supplemental no-action position on reporting and recordkeeping requirements affecting designated contract markets that list event contracts2.
Not financial advice. Do your own research.
What we passed on
- $NSPPENDING+9.4% since pass
Insiders also bought $7.8M of this HR-services company, but it just dropped 11% today on weak guidance and the technical picture is messier; better to wait for a stable base.
- $PATKPENDING-4.8% since pass
Insiders bought $3.7M but the stock is at $96, which is closer to its highs than its lows; the asymmetric setup is not there.
- $AREPENDING+8.2% since pass
Lab-space landlord with a $2.2M cluster buy, but commercial real estate has too many overhangs to chase a single insider signal.